الأخبار/Concert Pharmaceuticals Says its Alopecia Areata Investigational…Concert Pharmaceuticals Says its Alopecia Areata Investigational Drug CTP-543 Met Phase 3 Trial Endpoints٢٣ مايو ٢٠٢٢١١:٤٤ UTCCCNCE